Astrana Health [ASTH] vs Tenet Healthcare [THC] Detailed Stock Comparison
Astrana Health
NASDAQ
Loading...
Tenet Healthcare
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Astrana Health wins in 6 metrics, Tenet Healthcare wins in 13 metrics, with 0 ties. Tenet Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Astrana Health | Tenet Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 55.29 | 12.77 | Tenet Healthcare |
| Price-to-Book Ratio | 1.85 | 4.78 | Astrana Health |
| Debt-to-Equity Ratio | 83.20 | 158.70 | Astrana Health |
| PEG Ratio | -1.05 | 0.68 | Astrana Health |
| EV/EBITDA | 13.24 | 7.63 | Tenet Healthcare |
| Profit Margin (TTM) | 1.04% | 7.18% | Tenet Healthcare |
| Operating Margin (TTM) | 3.11% | 16.13% | Tenet Healthcare |
| EBITDA Margin (TTM) | 3.11% | 16.13% | Tenet Healthcare |
| Return on Equity | 5.44% | 29.65% | Tenet Healthcare |
| Return on Assets (TTM) | 3.25% | 7.58% | Tenet Healthcare |
| Free Cash Flow (TTM) | $44.17M | $1.12B | Tenet Healthcare |
| 1-Year Return | -48.66% | 28.20% | Tenet Healthcare |
| Price-to-Sales Ratio (TTM) | 0.55 | 0.87 | Astrana Health |
| Enterprise Value | $1.31B | $33.04B | Tenet Healthcare |
| EV/Revenue Ratio | 0.54 | 1.60 | Astrana Health |
| Gross Profit Margin (TTM) | 11.91% | 82.32% | Tenet Healthcare |
| Revenue per Share (TTM) | $50 | $220 | Tenet Healthcare |
| Earnings per Share (Diluted) | $0.52 | $15.90 | Tenet Healthcare |
| Beta (Stock Volatility) | 0.81 | 1.52 | Astrana Health |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Astrana Health vs Tenet Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Astrana Health | 0.42% | -0.38% | -2.17% | 19.54% | -1.43% | -10.34% |
| Tenet Healthcare | -1.60% | -0.72% | 3.79% | 15.41% | 66.86% | 59.53% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Astrana Health | -48.66% | -8.35% | 57.93% | 340.76% | 466.08% | 466.08% |
| Tenet Healthcare | 28.20% | 283.71% | 589.78% | 456.90% | 1,029.86% | 401.91% |
News Based Sentiment: Astrana Health vs Tenet Healthcare
Astrana Health
News based Sentiment: POSITIVE
Astrana Health reported strong financial performance with significant revenue and EPS growth, coupled with a very positive analyst outlook and a substantial potential upside. This combination of factors makes it a noteworthy development for investors.
Tenet Healthcare
News based Sentiment: POSITIVE
Tenet Healthcare experienced a very positive month, highlighted by a new 52-week high, a substantial earnings beat, and significant upgrades from major analysts. While insider selling is a minor concern, the overall narrative is strongly positive, suggesting continued growth and shareholder value creation. The company is executing well on its strategic initiatives and appears well-positioned for future success.
Performance & Financial Health Analysis: Astrana Health vs Tenet Healthcare
| Metric | ASTH | THC |
|---|---|---|
| Market Information | ||
| Market Cap | $1.39B | $17.99B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 324,610 | 859,380 |
| 90 Day Avg. Volume | 348,273 | 1,125,793 |
| Last Close | $28.87 | $199.76 |
| 52 Week Range | $21.20 - $63.20 | $109.82 - $205.99 |
| % from 52W High | -54.32% | -3.02% |
| All-Time High | $133.23 (Nov 15, 2021) | $210.00 (Sep 30, 2002) |
| % from All-Time High | -78.33% | -4.88% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.35% | 0.03% |
| Quarterly Earnings Growth | -0.51% | 0.11% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.07% |
| Operating Margin (TTM) | 0.03% | 0.16% |
| Return on Equity (TTM) | 0.05% | 0.30% |
| Debt to Equity (MRQ) | 83.20 | 158.70 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $15.58 | $42.44 |
| Cash per Share (MRQ) | $6.85 | $29.71 |
| Operating Cash Flow (TTM) | $130.56M | $2.46B |
| Levered Free Cash Flow (TTM) | $97.63M | $886.75M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Astrana Health vs Tenet Healthcare
| Metric | ASTH | THC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 55.29 | 12.77 |
| Forward P/E | 18.79 | 17.71 |
| PEG Ratio | -1.05 | 0.68 |
| Price to Sales (TTM) | 0.55 | 0.87 |
| Price to Book (MRQ) | 1.85 | 4.78 |
| Market Capitalization | ||
| Market Capitalization | $1.39B | $17.99B |
| Enterprise Value | $1.31B | $33.04B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.54 | 1.60 |
| Enterprise to EBITDA | 13.24 | 7.63 |
| Risk & Other Metrics | ||
| Beta | 0.81 | 1.52 |
| Book Value per Share (MRQ) | $15.58 | $42.44 |
Financial Statements Comparison: Astrana Health vs Tenet Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ASTH | THC |
|---|---|---|
| Revenue/Sales | $654.81M | $5.22B |
| Cost of Goods Sold | $576.84M | $907.00M |
| Gross Profit | $77.97M | $4.32B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $20.34M | $901.00M |
| EBITDA | $31.10M | $1.19B |
| Pre-Tax Income | $16.83M | $765.00M |
| Income Tax | $6.61M | $143.00M |
| Net Income (Profit) | $10.22M | $622.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ASTH | THC |
|---|---|---|
| Cash & Equivalents | $258.52M | $3.00B |
| Total Current Assets | $613.27M | $7.91B |
| Total Current Liabilities | $361.27M | $4.45B |
| Long-Term Debt | $433.40M | $13.08B |
| Total Shareholders Equity | $517.71M | $8.65B |
| Retained Earnings | $292.88M | $3.41B |
| Property, Plant & Equipment | $47.55M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ASTH | THC |
|---|---|---|
| Operating Cash Flow | $12.67M | $832.00M |
| Capital Expenditures | $-3.07M | $-162.00M |
| Free Cash Flow | $13.56M | $642.00M |
| Debt Repayment | $-428.38M | $-32.00M |
| Common Stock Repurchase | $-1.32M | $-348.00M |
Short Interest & Institutional Ownership Analysis
| Metric | ASTH | THC |
|---|---|---|
| Shares Short | 1.55M | 2.52M |
| Short Ratio | 4.49 | 2.22 |
| Short % of Float | 0.06% | 0.04% |
| Average Daily Volume (10 Day) | 324,610 | 859,380 |
| Average Daily Volume (90 Day) | 348,273 | 1,125,793 |
| Shares Outstanding | 47.93M | 95.11M |
| Float Shares | 37.56M | 87.59M |
| % Held by Insiders | 0.22% | 0.01% |
| % Held by Institutions | 0.53% | 1.00% |
Dividend Analysis & Yield Comparison: Astrana Health vs Tenet Healthcare
| Metric | ASTH | THC |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |